TBPH: Theravance Biopharma Company Short-Term Debt

Symbol and logo of brand Theravance Biopharma, Inc. (TBPH)

This price chart illustrates the performance of Theravance Biopharma (TBPH), where the metric value stands at 0.01. The business relies on payments from GSK and deep expertise in pulmonary treatment to develop inhalers with localized effects. Theravance Biopharma (TBPH) is creating a comprehensive respiratory therapy environment to improve patient quality of life. Current R&D is focused on final testing of selective agents prior to submitting documentation to regulatory authorities.

TBPH (Theravance Biopharma Inc) Company Short-Term Debts history from 07/04/2022 to 10/10/2026

Analytical breakdowns and data insights for company Theravance Corp (TBPH)

- current quotes and average value forecast:
Price Chart Theravance Biopharma, Inc.|TBPH - Fair Value Consensus
- market capitalization information:
Market Value Theravance Biopharma, Inc.|TBPH - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Theravance Biopharma|TBPH - Book Capitalization|Market Cap to Net Assets Ratio theravance.com|TBPH - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Theravance Biopharma|TBPH - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Theravance Biopharma|TBPH - Company Cumulative Indebtedness|Debts to Book Capitalization Theravance Biopharma, Inc.|TBPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Theravance Biopharma|Quick Liquidity theravance.com
- net income and valuation multiples indicators:
TBPH - Final Profit
Summary company analytics:Theravance Biopharma, Inc. (TBPH)
Mass-produced product of theravance.com

Investors are assessing the potential of Theravance Biopharma (TBPH) through the balance between R&D expenditures and debt load. This metric aggregates all liabilities maturing within one year, measuring the company's ability to service current loans. By analyzing the dynamics of the company's short-term debt, one can determine the efficiency of its liquidity management. For a research-oriented business with a strong academic foundation, a low level of borrowing guarantees the stability of development. This confirms the financial resilience of the issuer.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Tonix Pharmaceuticals Holding Corp. - Company Current Liabilities|Amount of Current Liabilities SXTC (SXT Pharmaceuticals)|Eupraxia Pharma - Company Short-Term Debts|Company Short-Term Loans and Borrowings BHST (BioHarvest Sciences Inc)|EXOZ: Company Short-Term Debts|Short-Term Debt Oramed Pharmaceuticals Inc. (ORMP)|Company Short-Term Debt Entera Bio Ltd|HYFT: Company Short-Term Loans and Borrowings|Company Short-Term Debts ABVC|Company Short-Term Debts Cumberland Corp (CPIX)|Quantum BioPharma Ltd - Company Current Liabilities|fibrogen.com - Company Short-Term Debt|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|RANI - Company Short-Term Debts|synergychc.com (SNYR) - Company Short-Term Debt|Company Short-Term Indebtedness RLYB|LEXX (Lexaria Bioscience Corp) - Company Short-Term Debts|Company Current Liabilities pulmatrix.com (PULM)|Company Short-Term Debts PTHL|APM - Short-Term Debt|Lyra Therapeutics, Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings IBO|TNF Pharma - Company Short-Term Debts|YCBD: Company Short-Term Debt|PRFX: Company Short-Term Debts|CYTO - Short-Term Debt Volume|Company Short-Term Debt Lipella|Short-Term Debt OptiNose Corp OPTN|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC: Current Liabilities|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Company Short-Term Loans and Borrowings QLI|ACELYRIN, Inc. - Company Short-Term Debts|TFFP - Company Short-Term Debts